Therapeutic Solutions International Inc's cost of sales deteriorated by -37.9 % year on year, relative to one quarter ago cost of sales fell by -34.46 % in Q3.
Therapeutic Solutions International Inc's cost of sales deteriorated by -37.9 % year on year, compare to one quarter ago cost of sales fell by -34.46 % in Q3.
Therapeutic Solutions International Inc's Comment on Supply Chain
The company collaborates with suppliers and manufacturers to ensure compliance with Good Manufacturing Practices for product preparation, packaging, storage, and shipment. Management is committed to adhering to FDA standards governing the labeling and marketing of dietary and nutritional supplements. These FDA regulations address identification, nutrition and ingredient labeling, nutrient and health claims, labeling for "high potency" and "antioxidant" claims, notification procedures, and pre-market notification for new dietary ingredients. The Dietary Supplement Health and Education Act of 1994 (DSHEA) establishes the regulatory framework for dietary supplements, including vitamins, minerals, herbs, amino acids, and other substances. The FDA typically does not regulate active ingredients in dietary supplements as drugs unless specific product claims invoke drug status. Additionally, the company complies with other U.S. regulations concerning taxes, labor, import/export, and intellectual property.
Therapeutic Solutions International Inc's Comment on Supply Chain
The company collaborates with suppliers and manufacturers to ensure compliance with Good Manufacturing Practices for product preparation, packaging, storage, and shipment. Management is committed to adhering to FDA standards governing the labeling and marketing of dietary and nutritional supplements. These FDA regulations address identification, nutrition and ingredient labeling, nutrient and health claims, labeling for "high potency" and "antioxidant" claims, notification procedures, and pre-market notification for new dietary ingredients. The Dietary Supplement Health and Education Act of 1994 (DSHEA) establishes the regulatory framework for dietary supplements, including vitamins, minerals, herbs, amino acids, and other substances. The FDA typically does not regulate active ingredients in dietary supplements as drugs unless specific product claims invoke drug status. Additionally, the company complies with other U.S. regulations concerning taxes, labor, import/export, and intellectual property.
Sources:
Therapeutic Solutions International Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Therapeutic Solutions International Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
